Understanding How PRP May Fit Into Personalized Fertility Care for IVF Patients

Beverly Hills, United States – July 22, 2026 / IVFLA Fertility /

BEVERLY HILLS, Calif., Monday, July 20, 2026 — IVFLA Fertility announced the introduction of a structured evaluation pathway for patients seeking information about platelet-rich plasma (PRP) fertility therapy as part of individualized reproductive care. The updated approach is designed to support clinical assessment for patients with poor ovarian response, diminished ovarian reserve, premature ovarian insufficiency, and selected in vitro fertilization (IVF) challenges using evidence-informed treatment planning.

The evaluation pathway was introduced in response to continued patient interest in emerging fertility treatment options and increasing discussion surrounding PRP in reproductive medicine. Current evidence suggests PRP is being studied for potential applications in ovarian response and endometrial receptivity, while published reviews indicate that additional high-quality research is needed to determine its effect on live birth outcomes.

As part of the updated process, patients undergo individualized fertility evaluations that may include review of ovarian reserve testing, prior IVF history, reproductive goals, and other clinical findings before PRP is considered. The assessment is intended to determine whether PRP discussion is appropriate within a broader fertility treatment strategy rather than as a standalone intervention.

The structured evaluation also incorporates review of ovarian reserve markers, including anti-Müllerian hormone (AMH), follicle-stimulating hormone (FSH), estradiol levels, and antral follicle count when clinically appropriate. These findings are considered alongside medical history, embryo development history, uterine evaluation, Male fertility test, and other diagnostic information to support individualized treatment planning.

According to the practice, PRP may be discussed in different clinical contexts, including intraovarian and endometrial applications, depending on a patient’s diagnosis and treatment objectives. The evaluation process emphasizes informed discussion of current research, potential risks, procedural considerations, and the limitations of available evidence before any treatment decisions are made.

The updated workflow also supports coordination between clinical evaluation, laboratory planning, IVF protocols, embryo development strategies, and ongoing patient monitoring when appropriate. The practice noted that PRP, when considered, is incorporated into comprehensive fertility planning rather than replacing established reproductive treatment approaches.

IVFLA Fertility stated that it will continue monitoring developments in reproductive medicine and evaluating emerging evidence to support individualized fertility care while maintaining a structured, evidence-informed approach to patient assessment.

Media Contact

IVFLA Fertility
Phone: (424) 340-6727
Email: drpresser@ivflafertility.com
Website: IVFLA Fertility

About IVFLA Fertility

IVFLA Fertility is a Beverly Hills, California-based reproductive medicine practice providing individualized fertility evaluation and treatment services. The practice offers advanced reproductive care supported by evidence-informed clinical assessment, coordinated treatment planning, and personalized patient care.